This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $305,000 to Segmedix, CO. aims to develop an AI-powered software system to improve the accuracy, consistency, and efficiency of prostate cancer diagnosis using magnetic resonance imaging (MRI). The project will create a style-encoding generative adversarial network (GAN) to harmonize prostate MRI images from different scanner vendors and field strengths, and a transformer-based UNETR segmentation model to generate precise 3D prostate outlines and uncertainty maps. This scanner-agnostic, confidence-aware segmentation tool has the potential to support real-time, human-in-the-loop clinical workflows, reduce unnecessary imaging, streamline radiologist workloads, and enable more consistent prostate cancer evaluations. The award period runs from July 15, 2025 to December 31, 2025.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| Not listed | $305.0k | 7/11/25 |